EconoTimesCynata to Present at the Preeminent Cell & Gene Therapy Investor Day in New YorkGlobeNewswire (press release)MELBOURNE, Australia, April 12, 2018 (GLOBE NEWSWIRE) — Australian stem cell and regenerative medicine company, Cynata Therapeut… Continue reading
EconoTimesCynata to Present at the Preeminent Cell & Gene Therapy Investor Day in New YorkGlobeNewswire (press release)MELBOURNE, Australia, April 12, 2018 (GLOBE NEWSWIRE) — Australian stem cell and regenerative medicine company, Cynata Therapeut… Continue reading
Boston Business JournalPfizer launches Duchenne gene therapy study, joining Sarepta and SolidBoston Business JournalPfizer has officially entered the race to cure Duchenne muscular dystrophy with gene therapy, joining Cambridge-based Sarepta Therapeuti… Continue reading
Lung Stem Cells (image)EurekAlert (press release)University of Iowa researchers have identified a new population of lung stem cells that appear to be important for repairing the airway following severe injury. The cells, which reside in submucosal glan… Continue reading
FiercePharma |
Can CAR-T and gene therapy cures really sustain biopharma? Not for all, analyst says
FiercePharma Ever since 2012 when Novartis invested in personalized CAR-T cancer treatments being developed at the University of Pennsylvania, analysts have pondered a difficult question: How can pharma companies profit from curing patients? Now Novartis’s CAR-T … |
News-Medical.net |
Advances in Stem Cell Labeling and Implications for Biological Research
News-Medical.net To explore the prospects of healthy tissue rejuvenation or damaged tissue regeneration, it is necessary to uncover the cellular mechanisms supporting the life cycle of stem cells. This means tracking the propagation of stem cells in living tissues … WideCells establishes ‘end-to-end’ stem cell serviceProactive Investors UK Lung stem cells repair airways after injuryEurekAlert (press release) A New Chapter in Stem Cell MedicineControlled Environments Magazine Digital Journal all 38 news articles » |
Market Realist |
Pfizer Advances in Cancer Cell Therapy with Allogene Agreement
Market Realist According to the terms of the agreement, upon completion of the transaction, Allogene has rights to Pfizer’s 16 pre-clinical CAR–T assets. Those assets are licensed from Servier, a French pharmaceutical company; Cellectis (CLLS), a French cell therapy … |
|
Scientists unlock path to use cell’s own nanoparticles as disease biomarkers
Science Daily He said it will also allow scientists to engineer EVs for use in tissue regeneration and help start a new chapter in stem–cell therapies and regenerative medicine. “The human body naturally directs EVs from stem cells to damaged tissue to assist in its … |